Calls
8
Lee Chang
CEO, Jangin Investment Club
Win Rate
-
return
-
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Feb 09
$89600.00
-
Obesity treatments are accelerating the lifting and aesthetic procedures market. Medical-beauty names combining pharma/biotech momentum and earnings, such as PharmaResearch, Hugel, Classys, and LNC Bio, are attractive especially on market corrections.
MedTech
Long
Feb 09
$251000.00
-
Obesity treatments are accelerating the lifting and aesthetic procedures market. Medical-beauty names combining pharma/biotech momentum and earnings, such as PharmaResearch, Hugel, Classys, and LNC Bio, are attractive especially on market corrections.
Pharma & Biotech
Long
Feb 09
$339000.00
-
Obesity treatments are accelerating the lifting and aesthetic procedures market. Medical-beauty names combining pharma/biotech momentum and earnings, such as PharmaResearch, Hugel, Classys, and LNC Bio, are attractive especially on market corrections.
Pharma & Biotech
Showing 3 of 8 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Lee Chang has 8 trade ideas tracked on Buzzberg across 12 tickers since February 2026.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
